Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hare

Showing results (571-580 of 873) with videos related to

Pageof 88
Sort By:
European Journal of Heart Failure|September 6, 2022
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial DiseasesBettina Heidecker, Noa Dagan, Ran Balicer, et al.
Circulation|January 25, 2006
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scarAlbert C Lardo, Marco A S Cordeiro, Caterina Silva, et al.
Journal of Clinical Medicine|June 10, 2022
Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate DataMariann Gyöngyösi, Evgeny Pokushalov, Aleksander Romanov, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2005
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarctionLuciano C Amado, Anastasios P Saliaris, Karl H Schuleri, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Ferenc G Rick, et al.
Hypertension (Dallas, Tex. : 1979)|October 7, 2004
Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junctionSeth A Townsend, Albert S Jung, Yen Shi Gillian Hoe, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 20, 2018
Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brainNikhil Mistry, C David Mazer, John G Sled, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2012
Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular functionFarideh Beigi, Daniel R Gonzalez, Khalid M Minhas, et al.
Vaccine|November 4, 2015
PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, AustraliaMichael J Binks, Sarah A Moberley, Anne Balloch, et al.
American Heart Journal|December 15, 2025
Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathyRoberto Bolli, Xian-Liang Tang, Joshua M Hare, et al.
Pageof 88

Showing results (571-580 of 873) with videos related to

Sort By:
Pageof 88
European Journal of Heart Failure|September 6, 2022
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial DiseasesBettina Heidecker, Noa Dagan, Ran Balicer, et al.
Circulation|January 25, 2006
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scarAlbert C Lardo, Marco A S Cordeiro, Caterina Silva, et al.
Journal of Clinical Medicine|June 10, 2022
Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate DataMariann Gyöngyösi, Evgeny Pokushalov, Aleksander Romanov, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2005
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarctionLuciano C Amado, Anastasios P Saliaris, Karl H Schuleri, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Ferenc G Rick, et al.
Hypertension (Dallas, Tex. : 1979)|October 7, 2004
Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junctionSeth A Townsend, Albert S Jung, Yen Shi Gillian Hoe, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 20, 2018
Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brainNikhil Mistry, C David Mazer, John G Sled, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2012
Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular functionFarideh Beigi, Daniel R Gonzalez, Khalid M Minhas, et al.
Vaccine|November 4, 2015
PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, AustraliaMichael J Binks, Sarah A Moberley, Anne Balloch, et al.
American Heart Journal|December 15, 2025
Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathyRoberto Bolli, Xian-Liang Tang, Joshua M Hare, et al.
Pageof 88